Active Motif Announces Global Distribution Deal with Arima Genomics
Active Motif will distribute Arima Genomics' advanced 3D genomics solutions worldwide. The agreement expands Active Motif's research portfolio and supports Arima's clinical diagnostics focus.
Active Motif has entered into an exclusive worldwide distribution agreement with Arima Genomics. This partnership will make Arima Genomics' advanced 3D genomics solutions available through Active Motif globally.
The agreement centers on Arima Genomics' Circular Architecture Reflection 3D Genome (CARLS) technology, which enables comprehensive, whole-genome 3D mapping and analysis of associated biological data.
For Active Motif, the deal enhances its capabilities in providing genomic research tools. Simultaneously, it aligns with Arima Genomics' strategic direction to leverage its CARLS platform for clinical diagnostic applications, a key area of future investment for the company.
Both companies anticipate that this collaboration will significantly advance genomic research and its applications in academic and commercial settings. The 3D genomics field is increasingly recognized for its potential in understanding diseases and developing novel therapeutics.